72 phenotypes from 6 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Slc4a1l11Jus51/Slc4a1l11Jus51 involves: C57BL/6J	abnormal definitive hematopoiesis	J:85113
	abnormal erythrocyte cell number	J:85113
	abnormal erythrocyte morphology	J:85113
	abnormal hemoglobin	J:85113
	anemia	J:85113
	decreased erythrocyte cell number	J:85113
	decreased hematocrit	J:85113
	decreased hemoglobin content	J:85113
	increased nucleated erythrocyte cell number	J:85113
	macrocytic anemia	J:85113
	postnatal lethality, complete penetrance	J:85113, J:109155
Slc4a1tm1Ahc/Slc4a1tm1Ahc involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal erythrocyte morphology	J:35637
	abnormal hemoglobin	J:35637
	abnormal immune system organ morphology	J:35637
	abnormal mean corpuscular volume	J:35637
	decreased body size	J:35637
	decreased erythrocyte cell number	J:35637
	decreased hematocrit	J:35637
	decreased hemoglobin content	J:35637
	decreased mean corpuscular volume	J:35637
	enlarged spleen	J:35637
	microcytic anemia	J:35637
	microcytosis	J:35637
	pallor	J:35637
	postnatal growth retardation	J:35637
	postnatal lethality, incomplete penetrance	J:35637
	spherocytosis	J:35637
Slc4a1tm1Dmb/Slc4a1tm1Dmb involves: 129S6/SvEvTac	abnormal bone marrow cell number	J:145243
	abnormal erythrocyte morphology	J:145243
	abnormal splenic cell ratio	J:145243
	increased erythrocyte osmotic fragility	J:145243
	poikilocytosis	J:145243
	reticulocytosis	J:145243
	stomatocytosis	J:145243
Slc4a1tm1Llp/Slc4a1+ involves: 129S4/SvJae * C57BL/6J	abnormal physiological response to xenobiotic	J:148154
Slc4a1tm1Llp/Slc4a1tm1Llp B6;129S4-Slc4a1tm1Llp/J	abnormal heart shape	J:120610
	cardiac hypertrophy	J:120610
	cardiac interstitial fibrosis	J:120610
	decreased body size	J:120610
	decreased body weight	J:120610
	decreased hematocrit	J:120610
	decreased ventricle muscle contractility	J:120610
	dilated heart left ventricle	J:120610
	hemolytic anemia	J:120610
	increased heart rate	J:120610
	pallor	J:120610
	postnatal lethality, incomplete penetrance	J:120610
	spherocytosis	J:120610
Slc4a1tm1Llp/Slc4a1tm1Llp involves: 129S4/SvJae * C57BL/6J	abnormal blood homeostasis	J:148154
	abnormal definitive hematopoiesis	J:35487
	abnormal erythrocyte morphology	J:35487
	abnormal kidney physiology	J:148154
	abnormal mean corpuscular hemoglobin	J:35487
	abnormal proerythroblast morphology	J:85322
	abnormal urine homeostasis	J:148154
	absent erythroid progenitor cell	J:85321
	acidemia	J:148154
	decreased circulating bicarbonate level	J:148154
	decreased creatinine clearance	J:148154
	decreased erythrocyte cell number	J:35487
	decreased hematocrit	J:35487, J:148154
	decreased hemoglobin content	J:35487
	decreased mean corpuscular volume	J:35487
	decreased urine osmolality	J:148154
	dehydration	J:148154
	enlarged spleen	J:35487
	hemolysis	J:148154
	hyperchromasia	J:35487
	increased blood osmolality	J:148154
	increased blood urea nitrogen level	J:148154
	increased circulating chloride level	J:148154
	increased circulating phosphate level	J:148154
	increased nucleated erythrocyte cell number	J:35487
	increased susceptibility to xenobiotic induced morbidity/mortality	J:148154
	increased urine calcium level	J:148154
	increased urine pH	J:148154
	kidney medulla atrophy	J:148154
	metabolic acidosis	J:148154
	microcytic anemia	J:35487
	microcytosis	J:35487
	nephrocalcinosis	J:148154
	pallor	J:35487
	poikilocytosis	J:35487
	polychromatophilia	J:35487
	polyuria	J:148154
	postnatal growth retardation	J:35487
	postnatal lethality, incomplete penetrance	J:35487
	premature death	J:148154
	reticulocytosis	J:35487, J:148154
	slow postnatal weight gain	J:148154
	spherocytosis	J:35487
	weight loss	J:148154
Slc4a1tm1Llp/Slc4a1wan involves: 129S1/Sv * 129X1/SvJ * C3H/HeJ * C57BL/6J	reticulocytosis	J:85321
Slc4a1tm1Phsl/Slc4a1+ involves: 129 * 129S6/SvEvTac * Black Swiss	reticulocytosis	J:152245
Slc4a1tm1Phsl/Slc4a1tm1Phsl involves: 129 * 129S6/SvEvTac * Black Swiss	abnormal erythrocyte morphology	J:152245
	decreased hematocrit	J:152245
	decreased hemoglobin content	J:152245
	decreased survivor rate	J:152245
	enlarged spleen	J:152245
	increased mean corpuscular volume	J:152245
	increased nucleated erythrocyte cell number	J:152245
	low mean erythrocyte cell number	J:152245
	pallor	J:152245
	reticulocytosis	J:152245
	thrombocytopenia	J:152245
Slc4a1wan/Slc4a1wan C3H/HeJ-Slc4a1wan/J	abnormal erythroblast morphology	J:85322
	anemia	J:85321
	binucleate	J:85322
	decreased erythrocyte cell number	J:85321
	decreased hematocrit	J:85321
	decreased hemoglobin content	J:85321
	decreased mean corpuscular volume	J:85321
	pallor	J:85321
	postnatal lethality, complete penetrance	J:85321
	reticulocytopenia	J:85321
	spherocytosis	J:85321